You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: February 7, 2025

Drug Price Trends for GNP SINUS SEVERE CAPLET


✉ Email this page to a colleague

« Back to Dashboard


Drug Price Trends for GNP SINUS SEVERE CAPLET

Average Pharmacy Cost for GNP SINUS SEVERE CAPLET

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
GNP SINUS SEVERE CAPLET 46122-0412-62 0.11364 EACH 2025-01-22
GNP SINUS SEVERE CAPLET 46122-0412-62 0.11597 EACH 2024-12-18
GNP SINUS SEVERE CAPLET 46122-0412-62 0.11453 EACH 2024-11-20
GNP SINUS SEVERE CAPLET 46122-0412-62 0.11741 EACH 2024-10-23
GNP SINUS SEVERE CAPLET 46122-0412-62 0.11283 EACH 2024-09-18
GNP SINUS SEVERE CAPLET 46122-0412-62 0.10857 EACH 2024-08-21
GNP SINUS SEVERE CAPLET 46122-0412-62 0.11551 EACH 2024-07-17
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Market Analysis and Price Projections for Sinus Severe Caplets: A Comprehensive Overview

Introduction to Sinus Severe Caplets

Sinus severe caplets, such as those offered by Tylenol, are designed to provide relief from symptoms associated with sinus congestion, headaches, and other respiratory allergies. These caplets typically contain a combination of active ingredients like acetaminophen, guaifenesin, and phenylephrine, which work together to alleviate pain, reduce congestion, and thin bronchial secretions[1][5].

Market Size and Growth

The market for sinusitis treatment, which includes products like sinus severe caplets, has been experiencing significant growth. As of 2023, the global sinusitis treatment market was valued at $2.78 billion and is projected to grow to $2.95 billion in 2024, with a compound annual growth rate (CAGR) of 6.1%. By 2028, the market is expected to reach $3.76 billion, driven by factors such as the rising prevalence of sinusitis, an increasing geriatric population, and advancements in treatment technologies[3].

Drivers of Market Growth

Increasing Prevalence of Sinusitis

The incidence of sinus infections is on the rise, affecting approximately 40% of the U.S. population. This increase is driven by various factors, including respiratory tract infections, compromised immunity, structural issues in the sinuses, and nasal polyps. The growing prevalence of sinusitis is a major driver for the demand of sinus severe caplets and other sinusitis treatment drugs[4].

Technological Advancements

Technological advancements in drug delivery systems, such as the development of nasal sprays, are also boosting the market. Innovations like Optinose XHANCE, which provide more effective and convenient ways to deliver medication directly to the sinuses, are gaining traction and investor attention[4].

Health Awareness and Government Support

Increased health awareness and government support for healthcare programs and research are additional factors contributing to the growth of the sinusitis treatment market. These initiatives help in improving diagnostic capabilities and treatment options, further driving the demand for products like sinus severe caplets[3].

Price Projections

Current Market Pricing

The pricing of sinus severe caplets can vary based on the brand, location, and distribution channel. However, these products generally fall within a competitive price range due to the presence of multiple market players. For instance, Tylenol Sinus Severe Daytime Caplets are typically priced in the range of $10 to $20 per package, depending on the size and retailer[1][5].

Future Pricing Trends

Given the projected growth of the sinusitis treatment market, prices are likely to remain competitive. However, several factors could influence future pricing:

  • Technological Advancements: New drug delivery technologies and innovative products may command a premium price due to their enhanced efficacy and convenience.
  • Generic and Branded Competition: The availability of generic alternatives could keep prices in check, while branded products with unique formulations or delivery systems might maintain or slightly increase their prices.
  • Regulatory Changes: Any changes in regulatory policies, such as the proposed removal of oral phenylephrine from the OTC monograph by the FDA, could impact pricing strategies[1].

Market Segmentation

The sinusitis treatment market, including sinus severe caplets, can be segmented based on several criteria:

Type of Sinusitis

  • Acute Sinusitis
  • Sub-Acute Sinusitis
  • Chronic Sinusitis

Each type has different treatment needs, which can influence the pricing and demand for specific products[4].

Treatment Options

  • Analgesics
  • Antihistamines
  • Corticosteroids
  • Antibiotics
  • Sulphonamides
  • Other treatments

The diversity in treatment options allows for a range of price points, catering to different patient needs and preferences[4].

Route of Administration

  • Oral
  • Topical
  • Others

Innovations in nasal sprays and other topical treatments are expected to grow in popularity, potentially affecting the pricing dynamics of oral medications like sinus severe caplets[4].

End-Users

  • Hospitals
  • Homecare
  • Specialty Clinics
  • Others

The distribution channel and end-user segment can also influence pricing, with hospital and specialty clinic settings often having different pricing structures compared to homecare and retail settings[4].

Key Takeaways

  • The sinusitis treatment market is growing due to increasing prevalence, technological advancements, and health awareness.
  • Sinus severe caplets are a significant part of this market, offering relief from sinus congestion and related symptoms.
  • Future pricing will be influenced by technological innovations, regulatory changes, and competition from generic and branded products.
  • Market segmentation based on type of sinusitis, treatment options, route of administration, and end-users will continue to shape the pricing and demand dynamics.

FAQs

Q: What are the active ingredients in Tylenol Sinus Severe Daytime Caplets? A: The active ingredients include acetaminophen (325 mg), guaifenesin (200 mg), and phenylephrine HCl (5 mg)[1].

Q: How is the sinusitis treatment market expected to grow in the next few years? A: The market is expected to grow from $2.78 billion in 2023 to $3.76 billion by 2028, with a CAGR of 6.2%[3].

Q: What are the major drivers of the sinusitis treatment market? A: The major drivers include the increasing prevalence of sinusitis, technological advancements, growing geriatric population, and increasing healthcare expenditure[3].

Q: How do technological advancements impact the pricing of sinus severe caplets? A: Technological advancements, such as new drug delivery systems, can lead to premium pricing for innovative products while keeping prices competitive for traditional formulations[4].

Q: What is the proposed FDA action on oral phenylephrine, and how might it affect the market? A: The FDA has proposed removing oral phenylephrine from the OTC monograph, which, if implemented, could influence the formulation and pricing of sinus severe caplets[1].

More… ↓

⤷  Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.